CLNN
Price
$4.25
Change
-$0.08 (-1.85%)
Updated
Jun 6 closing price
Capitalization
38.88M
LYRA
Price
$24.28
Change
-$1.05 (-4.15%)
Updated
Jun 6 closing price
Capitalization
32.18M
66 days until earnings call
Interact to see
Advertisement

CLNN vs LYRA

Header iconCLNN vs LYRA Comparison
Open Charts CLNN vs LYRABanner chart's image
Clene
Price$4.25
Change-$0.08 (-1.85%)
Volume$84.9K
Capitalization38.88M
Lyra Therapeutics
Price$24.28
Change-$1.05 (-4.15%)
Volume$247.9K
Capitalization32.18M
CLNN vs LYRA Comparison Chart
Loading...
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLNN vs. LYRA commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLNN is a Hold and LYRA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (CLNN: $4.25 vs. LYRA: $24.28)
Brand notoriety: CLNN and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLNN: 82% vs. LYRA: 29%
Market capitalization -- CLNN: $38.88M vs. LYRA: $32.18M
CLNN [@Biotechnology] is valued at $38.88M. LYRA’s [@Biotechnology] market capitalization is $32.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLNN’s FA Score shows that 0 FA rating(s) are green whileLYRA’s FA Score has 0 green FA rating(s).

  • CLNN’s FA Score: 0 green, 5 red.
  • LYRA’s FA Score: 0 green, 5 red.
According to our system of comparison, LYRA is a better buy in the long-term than CLNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLNN’s TA Score shows that 5 TA indicator(s) are bullish while LYRA’s TA Score has 7 bullish TA indicator(s).

  • CLNN’s TA Score: 5 bullish, 5 bearish.
  • LYRA’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, LYRA is a better buy in the short-term than CLNN.

Price Growth

CLNN (@Biotechnology) experienced а +33.23% price change this week, while LYRA (@Biotechnology) price change was +392.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

CLNN is expected to report earnings on Mar 24, 2025.

LYRA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLNN($38.9M) has a higher market cap than LYRA($32.2M). LYRA YTD gains are higher at: 135.271 vs. CLNN (-19.962). CLNN has higher annual earnings (EBITDA): -24.01M vs. LYRA (-44.7M). CLNN has less debt than LYRA: CLNN (20.9M) vs LYRA (34.4M). LYRA has higher revenues than CLNN: LYRA (1.19M) vs CLNN (350K).
CLNNLYRACLNN / LYRA
Capitalization38.9M32.2M121%
EBITDA-24.01M-44.7M54%
Gain YTD-19.962135.271-15%
P/E RatioN/AN/A-
Revenue350K1.19M30%
Total Cash9.83MN/A-
Total Debt20.9M34.4M61%
FUNDAMENTALS RATINGS
CLNN: Fundamental Ratings
CLNN
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLNNLYRA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 16 days ago
89%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRG22.590.69
+3.15%
Kite Realty Group Trust
CZNC18.570.50
+2.77%
Citizens & Northern Corp
ELME16.170.07
+0.43%
Elme Communities
KVUE21.730.08
+0.37%
Kenvue
IPA0.67-0.03
-4.22%
ImmunoPrecise Antibodies Ltd

CLNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLNN has been loosely correlated with LYRA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLNN jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLNN
1D Price
Change %
CLNN100%
-1.85%
LYRA - CLNN
38%
Loosely correlated
-4.15%
VERA - CLNN
35%
Loosely correlated
-25.89%
KZIA - CLNN
33%
Poorly correlated
+5.71%
BPMC - CLNN
30%
Poorly correlated
-0.04%
GOSS - CLNN
30%
Poorly correlated
+5.56%
More

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been closely correlated with GLYC. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if LYRA jumps, then GLYC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
-4.15%
GLYC - LYRA
75%
Closely correlated
-2.42%
VERA - LYRA
61%
Loosely correlated
-25.89%
EYPT - LYRA
58%
Loosely correlated
+8.36%
KYMR - LYRA
51%
Loosely correlated
-0.08%
BPMC - LYRA
43%
Loosely correlated
-0.04%
More